Basis of Presentation - Liquidity (Details) - USD ($)	3 Months Ended				6 Months Ended
	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Working Capital Deficiency	$ (400,000)				$ (400,000)
Deferred revenue	3,576,161				3,576,161		$ 4,557,317
Total Stockholders' Deficit	(15,524,704)				(15,524,704)		(12,965,983)
Net income (loss)	(931,226)	$ (1,109,406)	$ (362,300)	$ 408,295	(2,040,632)	$ 45,995
Net cash used in operating activities					(1,309,694)	$ (345,285)
Cash and cash equivalents	1,808,118				1,808,118		3,181,209
Cash, Period Increase (Decrease), Excluding Exchange Rate Effect					(1,400,000)
Series A redeemable convertible preferred stock, redemption value	$ 15,129,623				$ 15,129,623		$ 14,490,274